SCHEMBL17345969

SCHEMBL17345969

CSCCNCCN1CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.43
PAOX Q6QHF9 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
DUSP3 P51452 1/20 0.40
ACE2 Q9BYF1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
TSHR P16473 1/20 0.39
KEAP1 Q14145 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17345963 0.89 PAOX (0.48) KDM1APAOXCA12CA1CA2
SCHEMBL4401738 0.84 CA12 (0.53) KDM1APAOXCA12CA1CA2
SCHEMBL17345962 0.82 CARM1 (0.50) KDM1ACA12CA1CA2CA9
SCHEMBL17345967 0.82 PAOX (0.55) KDM1APAOXALDH1A1CYP2D6HPGD
SCHEMBL6037476 0.80 HSP90AA1 (0.47) ALDH1A1L3MBTL1HPGDDUSP3SMN1; SMN2
SCHEMBL13520192 0.79 TSHR (0.49) KDM1APAOXCA12CA1CA2
SCHEMBL2994842 0.78 SMN1; SMN2 (0.44) KDM1APAOXCA12CA1CA2
SCHEMBL2703833 0.77 CARM1 (0.48) KDM1APAOXCA12CA1CA2
SCHEMBL39800 0.76 CA12 (0.47) KDM1APAOXCA12CA1CA2
SCHEMBL9881188 0.76 KEAP1 (0.54) PAOXALDH1A1CYP2D6HPGDDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN KDM1A 4774/4885PAOX 49/4885CA12 1341/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN KDM1A 4774/4885PAOX 49/4885CA12 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.